FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3159795186> ?p ?o ?g. }

• W3159795186 endingPage "832" @default.
• W3159795186 startingPage "832" @default.
• W3159795186 abstract "Background: This study monitored total anti-SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) RBD (receptor-binding domain) antibodies levels in a large population of healthcare workers undergoing mRNA COVID-19 vaccination. Methods. The study population consisted of employees of Pederzoli Hospital of Peschiera del Garda (Verona, Italy), who underwent voluntary vaccination with two doses of COVID-19 mRNA BNT162b2 (Comirnaty; Pfizer Inc). Venous blood was drawn immediately before the first vaccine dose, as well as 21 days (immediately before second vaccine dose) and 50 days afterwards. Humoral response was assessed with Roche Elecsys Anti-SARS-CoV-2 S total antibodies, on Roche Cobas 6000 (Roche Diagnostics). Results: The final study population consisted of 925 subjects (mean age, 44 ± 13 years; 457 women), 206 (22.3%) anti-SARS-CoV-2 baseline seropositive. The increase of total anti-SARS-CoV-2 RBD antibodies levels 21 days after the first vaccine dose was ~3 orders of magnitude higher in seropositive than in seronegative individuals (11782 vs. 42 U/mL; p < 0.001). Total anti-SARS-CoV-2 RBD antibodies levels further increased by over 30-fold after the second vaccine dose in baseline seronegative subjects, while such increase was only ~1.3-fold in baseline seropositive subjects. In multivariate analysis, total anti-SARS-CoV-2 RBD antibodies level was inversely associated with age after both vaccine doses and male sex after the second vaccine dose in baseline seronegative subjects, while baseline antibodies value significantly predicted immune response after both vaccine doses in baseline seropositive recipients. Conclusion: Significant difference exists in post-mRNA COVID-19 vaccine immune response in baseline seronegative and seropositive subjects, which seems dependent on age and sex in seronegative subjects, as well as on baseline anti-SARS-CoV-2 antibodies level in seropositive patients." @default.
• W3159795186 created "2021-05-10" @default.
• W3159795186 creator A5013630793 @default.
• W3159795186 creator A5026075266 @default.
• W3159795186 creator A5036580931 @default.
• W3159795186 creator A5039747681 @default.
• W3159795186 creator A5042224614 @default.
• W3159795186 creator A5046658579 @default.
• W3159795186 creator A5068599898 @default.
• W3159795186 creator A5073522064 @default.
• W3159795186 date "2021-05-04" @default.
• W3159795186 modified "2023-10-17" @default.
• W3159795186 title "Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination" @default.
• W3159795186 cites W3035622479 @default.
• W3159795186 cites W3091832566 @default.
• W3159795186 cites W3093038587 @default.
• W3159795186 cites W3119163550 @default.
• W3159795186 cites W3120079690 @default.
• W3159795186 cites W3120925808 @default.
• W3159795186 cites W3124144456 @default.
• W3159795186 cites W3125765477 @default.
• W3159795186 cites W3127600917 @default.
• W3159795186 cites W3128813257 @default.
• W3159795186 cites W3130424776 @default.
• W3159795186 cites W3131348899 @default.
• W3159795186 cites W3133255795 @default.
• W3159795186 cites W3133659396 @default.
• W3159795186 cites W3133814922 @default.
• W3159795186 cites W3133936567 @default.
• W3159795186 cites W3134500809 @default.
• W3159795186 cites W3134561125 @default.
• W3159795186 cites W3134757598 @default.
• W3159795186 cites W3135260899 @default.
• W3159795186 cites W3135405821 @default.
• W3159795186 cites W3135847809 @default.
• W3159795186 cites W3136513112 @default.
• W3159795186 cites W3137149211 @default.
• W3159795186 cites W3137206838 @default.
• W3159795186 cites W3137440084 @default.
• W3159795186 cites W3137769009 @default.
• W3159795186 cites W3138447431 @default.
• W3159795186 cites W3138476633 @default.
• W3159795186 cites W3138885704 @default.
• W3159795186 cites W3139490202 @default.
• W3159795186 cites W3140994866 @default.
• W3159795186 cites W3142436924 @default.
• W3159795186 cites W3145186977 @default.
• W3159795186 cites W3145760592 @default.
• W3159795186 cites W3146538993 @default.
• W3159795186 cites W3146894320 @default.
• W3159795186 cites W3148116959 @default.
• W3159795186 cites W3148832547 @default.
• W3159795186 cites W3149188151 @default.
• W3159795186 cites W3150351745 @default.
• W3159795186 cites W3150786652 @default.
• W3159795186 cites W3151209183 @default.
• W3159795186 cites W4205098351 @default.
• W3159795186 doi "https://doi.org/10.3390/diagnostics11050832" @default.
• W3159795186 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8147939" @default.
• W3159795186 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34064509" @default.
• W3159795186 hasPublicationYear "2021" @default.
• W3159795186 type Work @default.
• W3159795186 sameAs 3159795186 @default.
• W3159795186 citedByCount "73" @default.
• W3159795186 countsByYear W31597951862021 @default.
• W3159795186 countsByYear W31597951862022 @default.
• W3159795186 countsByYear W31597951862023 @default.
• W3159795186 crossrefType "journal-article" @default.
• W3159795186 hasAuthorship W3159795186A5013630793 @default.
• W3159795186 hasAuthorship W3159795186A5026075266 @default.
• W3159795186 hasAuthorship W3159795186A5036580931 @default.
• W3159795186 hasAuthorship W3159795186A5039747681 @default.
• W3159795186 hasAuthorship W3159795186A5042224614 @default.
• W3159795186 hasAuthorship W3159795186A5046658579 @default.
• W3159795186 hasAuthorship W3159795186A5068599898 @default.
• W3159795186 hasAuthorship W3159795186A5073522064 @default.
• W3159795186 hasBestOaLocation W31597951861 @default.
• W3159795186 hasConcept C126322002 @default.
• W3159795186 hasConcept C159654299 @default.
• W3159795186 hasConcept C203014093 @default.
• W3159795186 hasConcept C22070199 @default.
• W3159795186 hasConcept C2779134260 @default.
• W3159795186 hasConcept C2908647359 @default.
• W3159795186 hasConcept C3007834351 @default.
• W3159795186 hasConcept C3008058167 @default.
• W3159795186 hasConcept C524204448 @default.
• W3159795186 hasConcept C71924100 @default.
• W3159795186 hasConcept C99454951 @default.
• W3159795186 hasConceptScore W3159795186C126322002 @default.
• W3159795186 hasConceptScore W3159795186C159654299 @default.
• W3159795186 hasConceptScore W3159795186C203014093 @default.
• W3159795186 hasConceptScore W3159795186C22070199 @default.
• W3159795186 hasConceptScore W3159795186C2779134260 @default.
• W3159795186 hasConceptScore W3159795186C2908647359 @default.
• W3159795186 hasConceptScore W3159795186C3007834351 @default.
• W3159795186 hasConceptScore W3159795186C3008058167 @default.
• W3159795186 hasConceptScore W3159795186C524204448 @default.
• W3159795186 hasConceptScore W3159795186C71924100 @default.

• next